Crossover Medical Technology entered the industry of Research and Development Laboratories in 2009 and has grown to employ 1 to 4 people, generating an annual revenue of $0 to $49.999. The NAICS classifies this business under the code 541712, which describes it as a Research and Development Laboratories. For further clarification, the SIC classifies this business under the code 8731 and described it as a Research and Development Laboratories. The business provides service to the B2B market.
To acquire more information, please contact by calling (949) 262-9610 during business hours. You can also write to the business’ Single Location at 18 Arbusto, Irvine, California CA 92606. You can also visit the company’s website at . View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Crossover Medical Technology |
| Place of Business: | 18 Arbusto, Irvine, CA 92606 |
| Contact Number: | (949) 262-9610 |
| Type of Service: | Research and Development Laboratories |
| SIC Number: | 8731 |
| NAICS Number: | 541712 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2009 |
| Income/Year: | $0 to $49.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Crossover Medical Technology is a company operating from Orange, California providing professional Research and Development Laboratories and relevant B2B variables. It was founded in 2009 and registered with the SIC code 8731 as Research and Development Laboratories, and with the NAICS code 541712 as Research and Development Laboratories.
With a current employee count of 1 to 4, Crossover Medical Technology has gone to report making $0 to $49.999 per annum on its journey towards growth. This company invites you to contact its representative at (949) 262-9610 for related queries, or to locate its Single Location using the coordinates .
The Single Location can also be found at the street address 18 Arbusto in Irvine, California 92606 and can be engaged online through the company website at , the company Twitter , and Facebook page .